Skip to Menu Skip to Search Contact Us Skip to Content

About

This webcast will describe strategies and best practices for developing and implementing virus testing programs and explain test methods for virus detection and quantitation during various biopharmaceutical manufacturing phases.

Starts

May 20, 2014, 11:00

Ends

May 27, 2014, 11:00

Effective Viral Contamination Testing Programs for Biologics Product Manufacturing

This webcast is brought to you by SGS, in collaboration with BioPharm International. During this event experts will describe strategies and best practices for developing and implementing effective virus testing programs, including a review of regulatory guidance. In addition, you will learn about test methods for virus detection and quantitation during various biopharmaceutical manufacturing phases. A range of testing technologies, including in vitro adventitious virus assays, PCR, ELISA, plaque assays, and electron microscopy, as well as sampling methods, will be discussed.

Key Learning Objectives:

·          Develop a comprehensive plan for effective testing for viral contaminants

·          Review current testing methods and revise current methods to ensure product safety

·          Understand pros and cons for various methods for detecting viruses

Moderator:
Rita Peters

Editorial Director
Pharmaceutical Technology

Speakers:
Ruth Paul
Director
Paul Regulatory Consulting Services

Archie Lovatt
Scientific Operations Director
SGS Vitrology

Euan W. Milne
Electron Microscopist
SGS Life Science Services

The webinar will be presented on:
US
Tuesday, May 20 at 11:00 am EDT
EU Tuesday, May 27 at 11:00 am CET

IMPORTANT - PLEASE READ
This is a FREE streaming audio Webcast and does not require a phone line. If you have any questions regarding this Webcast, please contact Sara Barschdorf,
sbarschdorf@advanstar.com
.